These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17390016)

  • 1. Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.
    Oudin C; Bonnetain F; Boidot R; Végran F; Soubeyrand MS; Arnould L; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2007 May; 30(5):1145-51. PubMed ID: 17390016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
    Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H; Müller V; Stahmann N; Pantel K
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.
    Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA
    Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.
    Nowacka-Zawisza M; Bryś M; Hanna RM; Zadrozny M; Kulig A; Krajewska WM
    Pol J Pathol; 2006; 57(2):83-9. PubMed ID: 17019970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations on chromosome 19, 20, 21, 22, and X detected by loss of heterozygosity analysis in retinoblastoma.
    Huang Q; Choy KW; Cheung KF; Lam DS; Fu WL; Pang CP
    Mol Vis; 2003 Oct; 9():502-7. PubMed ID: 14551532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite alterations plasma DNA of primary breast cancer patients.
    Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
    Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.
    Boidot R; Vegran F; Lizard-Nacol S
    Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity and microsatellite instability in the region including BRCA1 of breast cancer in Chinese].
    Cui J; Shen F; Jiang F; Wang Y; Bian J; Shen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):348-50. PubMed ID: 9845764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation.
    Takimoto Y; Shimazui T; Akaza H; Sato N; Noguchi M
    Cancer; 2001 Jan; 91(2):362-70. PubMed ID: 11180083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic instability in human malignant uveal melanomas].
    Proniewska-Skretek E; Pepiński W; Skawrońska M; Mariak Z; Zalewska R; Janica J; Stankiewicz A
    Klin Oczna; 2003; 105(6):401-5. PubMed ID: 15049265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
    Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of some macrosatillite sites of chromosome 19 in primary gastric carcinoma with loss of heterozygosity].
    Jiang M; Xu L; Zhao Y; Fang HH; Chen ZH; Gao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):455-9. PubMed ID: 17611325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
    Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
    Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.